Showing results (261-270 of 283) with videos related to
Sort By:
Pageof 29
European Journal of Medicinal Chemistry|July 24, 2012
Structure-activity relationships of novel substituted naphthalene diimides as anticancer agentsAndrea Milelli, Vincenzo Tumiatti, Marialuisa Micco, et al.Journal of Experimental & Clinical Cancer Research : CR|March 26, 2023
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myelomaFrancesca Scionti, Giada Juli, Roberta Rocca, et al.Journal of Translational Medicine|October 23, 2022
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid RhamnetinDaniele Caracciolo, Giada Juli, Caterina Riillo, et al.Oncotarget|October 14, 2015
Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapyCristina Talarico, Lucia D'Antona, Domenica Scumaci, et al.European Journal of Medicinal Chemistry|October 15, 2022
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomasMarilia Barreca, Virginia Spanò, Roberta Rocca, et al.Journal of Medicinal Chemistry|July 15, 2011
New insight into the central benzodiazepine receptor-ligand interactions: design, synthesis, biological evaluation, and molecular modeling of 3-substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compoundsMaurizio Anzini, Salvatore Valenti, Carlo Braile, et al.European Journal of Medicinal Chemistry|April 3, 2025
O-derivatization of natural tropolone and β-thujaplicin leading to effective inhibitors of human carbonic anhydrases IX and XIIFrancesco Melfi, Ilaria D'Agostino, Simone Carradori, et al.Journal of Medicinal Chemistry|August 3, 2023
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic ActivityMaria Dichiara, Francesca Alessandra Ambrosio, Sang Min Lee, et al.ACS Chemical Neuroscience|March 5, 2016
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative StressFrancesca Aiello, Mariateresa Badolato, Federica Pessina, et al.Chemmedchem|December 5, 2019
Pyrazolones Activate the Proteasome by Gating Mechanisms and Protect Neuronal Cells from β-Amyloid ToxicityAnna Maria Santoro, Valeria Lanza, Francesco Bellia, et al.Pageof 29